160 related articles for article (PubMed ID: 12654975)
1. Myasthenia gravis: a higher than expected incidence in the elderly.
Aragonès JM; Bolíbar I; Bonfill X; Bufill E; Mummany A; Alonso F; Illa I
Neurology; 2003 Mar; 60(6):1024-6. PubMed ID: 12654975
[TBL] [Abstract][Full Text] [Related]
2. Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.
Mombaur B; Lesosky MR; Liebenberg L; Vreede H; Heckmann JM
Muscle Nerve; 2015 Apr; 51(4):533-7. PubMed ID: 25060190
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of patients with myasthenia gravis associated with autoimmune diseases.
Kanazawa M; Shimohata T; Tanaka K; Nishizawa M
Eur J Neurol; 2007 Dec; 14(12):1403-4. PubMed ID: 17941854
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of myasthenia gravis in the Catalan county of Osona.
Aragonès JM; Altimiras J; Roura P; Alonso F; Bufill E; Munmany A; Alfonso S; Illa I
Neurologia; 2017; 32(1):1-5. PubMed ID: 25449965
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis and elderly people.
Schon F; Drayson M; Thompson RA
Age Ageing; 1996 Jan; 25(1):56-8. PubMed ID: 8670530
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.
Santos E; Coutinho E; Moreira I; Silva AM; Lopes D; Costa H; Silveira F; Nadais G; Morais H; Martins J; Branco MC; Veiga A; Silva RS; Ferreira A; Sousa F; Freijo M; Matos I; André R; Negrão L; Fraga C; Santos M; Sampaio M; Lopes C; Leite MI; Gonçalves G
Muscle Nerve; 2016 Sep; 54(3):413-21. PubMed ID: 26851892
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of seropositive myasthenia gravis in Greece.
Poulas K; Tsibri E; Kokla A; Papanastasiou D; Tsouloufis T; Marinou M; Tsantili P; Papapetropoulos T; Tzartos SJ
J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):352-6. PubMed ID: 11511710
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
Niks EH; Kuks JB; Verschuuren JJ
J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
[TBL] [Abstract][Full Text] [Related]
9. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
10. Juvenile myasthenia gravis in Norway: A nationwide epidemiological study.
Popperud TH; Boldingh MI; Brunborg C; Faiz KW; Heldal AT; Maniaol AH; Müller KI; Rasmussen M; Øymar K; Kerty E
Eur J Paediatr Neurol; 2017 Mar; 21(2):312-317. PubMed ID: 27666466
[TBL] [Abstract][Full Text] [Related]
11. Incidence of seropositive myasthenia gravis in Cape Town and South Africa.
Bateman KJ; Schinkel M; Little F; Liebenberg L; Vincent A; Heckmann JM
S Afr Med J; 2007 Oct; 97(10):959-62. PubMed ID: 18000579
[TBL] [Abstract][Full Text] [Related]
12. Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
Somnier FE
Neurology; 2005 Sep; 65(6):928-30. PubMed ID: 16186537
[TBL] [Abstract][Full Text] [Related]
13. Clinical features of patients with Myasthenia gravis from the Henan province, China.
Gao F; Zhao X; Zhang J; Cui X; Zhang Y; Li Q; Liu P; Fang H; Du Y; Zhang Q; Yang J; Zhang Y
Muscle Nerve; 2016 May; 53(5):711-6. PubMed ID: 26403759
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis in the county of Viborg, Denmark.
Sørensen TT; Holm EB
Eur Neurol; 1989; 29(3):177-9. PubMed ID: 2731568
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Ocular Features of Pediatric Myasthenias.
Mansukhani SA; Bothun ED; Diehl NN; Mohney BG
Am J Ophthalmol; 2019 Apr; 200():242-249. PubMed ID: 30653958
[TBL] [Abstract][Full Text] [Related]
16. Evidence of underdiagnosis of myasthenia gravis in older people.
Vincent A; Clover L; Buckley C; Grimley Evans J; Rothwell PM;
J Neurol Neurosurg Psychiatry; 2003 Aug; 74(8):1105-8. PubMed ID: 12876244
[TBL] [Abstract][Full Text] [Related]
17. Seropositive myasthenia gravis: a nationwide epidemiologic study.
Heldal AT; Owe JF; Gilhus NE; Romi F
Neurology; 2009 Jul; 73(2):150-1. PubMed ID: 19597135
[No Abstract] [Full Text] [Related]
18. A population based epidemiological study on myasthenia gravis in Estonia.
Oöpik M; Kaasik AE; Jakobsen J
J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1638-43. PubMed ID: 14638881
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica.
McKeon A; Lennon VA; Jacob A; Matiello M; Lucchinetti CF; Kale N; Chan KH; Weinshenker BG; Apiwattinakul M; Wingerchuk DM; Pittock SJ
Muscle Nerve; 2009 Jan; 39(1):87-90. PubMed ID: 19086079
[TBL] [Abstract][Full Text] [Related]
20. Geoepidemiology of myasthenia gravis [corrected].
Meyer A; Levy Y
Autoimmun Rev; 2010 Mar; 9(5):A383-6. PubMed ID: 19922815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]